Peroxynitrite Mediates Nitric Oxide-Induced Blood-Brain Barrier Damage

Neurochemical Research

Volumn 29, Issue 3, 2004, Pages 579-587

  Tan, Kian H ^a   Harrington, Sian ^a   Purcell, Wendy M ^a   Hurst, Roger D ^a,b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b Mirinz Centre   (New Zealand)

Author keywords

Blood brain barrier; Endothelial cells; Inflammation; Peroxynitrite

Indexed keywords

3 NITROTYROSINE; ACETOACETIC ACID; ANTIBODY; DICHLOROFLUORESCEIN; NITRIC OXIDE; PEROXYNITRITE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORESCENCE; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BLOOD-BRAIN BARRIER; CELL LINE; CELL SURVIVAL; ENDOTHELIUM, VASCULAR; HUMANS; KINETICS; METALLOPORPHYRINS; MODELS, BIOLOGICAL; NITRIC OXIDE; PEROXYNITROUS ACID; REACTIVE OXYGEN SPECIES; UMBILICAL VEINS;

ANIMALIA;

EID: 1542348201     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000014828.32200.bd     Document Type: Article

References (34)

1. Böje, K. M. K. 1996. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res. 720:75-83.
2. Merrill, J. E. and Murphy, S. P. 1997. Inflammatory events at the blood-brain barrier: Regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav. Immun. 11:245-263.
3. Hurst, R. D. and Dobbie, M. S. 2001. NO and blood-brain barrier permeability. Biochemist 23:15-19.
4. Hurst, R. D. and Clark, J. B. 1997. Nitric oxide induced blood-brain barrier dysfunction is not mediated by inhibition of mitochondrial respiratory chain activity and/or energy depletion. Nitric Oxide Biol. Chem. 1:121-129.
5. Hurst, R. D., Azam, S., Hurst, A., and Clark, J. B. 2001. Nitric oxide induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier. Brain Res. 894:181-188.
6. Liu, J. S., Zhao, M. L., Brosnan, C. F., and Lee, S. C. 2001. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158:2057-2066.
7. Hurst, R. D. and Fritz, I. B. F. 1996. Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J. Cell. Physiol. 167:81-88.
8. Hurst, R. D. and Clark, J. B. 1998. Alterations in transendothelial electrical resistance by vasoactive agonists and cyclic AMP in a blood-brain barrier model system. Neurochem. Res. 23:149-154.
9. Tan, K. H., Dobbie, M. S., Felix, R. A., Barrand, M. A., and Hurst, R. D. 2001. A comparison of the induction of immortalised endothelial cell impermeability by astrocytes. Neuroreport 12:1-6.
10. Stern, M. K., Jensen, M. P., and Kramer, K. 1996. Peroxynitrite decomposition catalysts. J. Am. Chem. Soc. 118:8735-8736.
11. Salemini, D., Wang, Z.-Q., Stern, M. K., Currie, M. G., and Misko, T. P. 1998. Peroxynitrite decomposition catalysts: Therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. USA 95:2659-2663.
12. Misko, T. P., Highkin, M. K., Veenhuizen, A. W., Manning, P. T., Stern, M. K., Currie, M. G., and Salvemini, D. 1998. Characterisation of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273:15646-15653.
13. Shimanovich, R. and Groves, J. T. 2001. Mechanisms of peroxynitrite decomposition catalysed by FeTMPS, a bioactive sulfonated iron porphyrin. Arch. Biochem. Biophys. 387:307-317.
14. Archer, S. 1993. Measurement of nitric oxide in biological models. FASEB J. 7:349-360.
15. Polli, J. W., Humphreys, J. E., Wring, S. A., Burnette, T. C., Read, K. D., Hersey, A., Butina, D., Bertolotti, L., Pugnaghi, F., and Serabjit-Singh, C. J. 2000. A comparison of Madin-Darby canine kidney cells and bovine brain endothelial cells as a blood-brain barrier screen in early drug discovery. Pages 271-289, in Balls, M., van Zeller, A. M., and Halder, M. E. (eds.), Progress in the Reduction, Refinement and Replacement of Animal Experimentation. Elsevier, New York.
16. Radi, R., Peluffo, G., Alvarez, M. A., Naviliat, M., and Cayota, A. 2001. Unraveling peroxynitrite formation in biological systems. Free Rad. Biol. Med. 30:463-488.
17. Wang, H. and Joseph, J. A. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Rad. Biol. Med. 27:612-616.
18. Kooy, N. W., Royall, J. A., and Ischiropoulos, H. 1997. Oxidation of 2′, 7′-dichlorofluorescein by peroxynitrite. Free Rad. Res. 27:245-254.
19. Hooper, D. C., Kean, R. B., Scott, G. S., Spitsin, S. V., Mikheeva, T., Morimoto, K., Bette, M., Röhrenbeck, A. M., Dietzschold, B., and Weihe, E. 2001. The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J. Immunol. 167:3470-3477.
20. Hooper, D. C., Scott, G. S., Zborek, A., Mikheeva, T., Kean, R. B., Koprowski, H., and Spitsin, S. V. 2000. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes and tissue damage in a mouse model of multiple sclerosis. FASEB J. 14:691-698.
21. Spitsin, S. V., Scott, G. S., Kean, R. B., Mikheeva, T., and Hooper, D. C. 2000. Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci. Lett. 292:137-141.
22. Gursoy-Ozdemir, Y., Bolay, H., Saribas, O., and Dalkara, T. 2000. Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 31:1974-1980.
23. Xu, J., He, L. M., Ahmed, S. H., Chen, S. W., Goldberg, M. P., Beckman, J. S., and Hsu, C. Y. 2000. Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 31:1744-1751.
24. Nag, S., Picard, P., and Stewart, D. J. 2001. Expression of nitric oxide synthases and nitrotyrosine during blood-brain barrier breakdown and repair after cold injury. Lab. Invest. 81:41-49.
25. Brown, G. C. 1995. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369:136-139.
26. Bolanos, J. P., Peuchen, S., Heales, S. J. R., Land, J. M., and Clark, J. B. 1994. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:910-916.
27. Imaizumi, S., Kondo, T., Deli, M. A., Gobbel, G., Joo, F., Epstein, C. J., Yoshim, T., and Chan, P. H. 1996. The influence of oxygen free radicals on the permeability of the monolayer of cultured brain endothelial cells. Neurochem. Int. 29:205-211.
28. Mayhan, W. G. 2000. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res. 866:101-108.
29. Poderoso, J. J., Carreras, M. C., Lisdero, C., Riobo, N., Schopfer, F., and Boveris, A. 1996. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 238:85-92.
30. Sharpe, M. A. and Cooper, C. E. 1998. Interaction of peroxynitrite with mitochondrial cytochrome oxidase: Catalytic production of nitric oxide and irreversible inhibition of enzyme activity. J. Biol. Chem. 273:30961-30972.
31. Radi, R., Rodriguez, M., Castro, L., and Telleri, R. 1994. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308:89-95.
32. Bolanos, J. P., Heales, S. J. R., Land, J. M., and Clark, J. B. 1995. Effect of peroxynitrite on the mitochondrial respiratory chain: Differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1965-1972.
33. Tsukada, N., Miyagi, K., Matsuda, M., and Yanagisawa, N. 1995. Soluble E-selection in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T lymphotropic virus type 1 associated myelopathy. Neurology 45:1914-1918.
34. Tsukada, N., Miyagi, K., Matsuda, M., and Yanagisawa, N. 1995. Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type 1 associated myelopathy. J. Neuroimmunol. 56:113-116.